Plain-English translation of NCT05333523 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new approach to treating throat cancer (squamous cell carcinoma of the oropharynx, larynx, or hypopharynx) using radiation therapy. Instead of automatically radiating both sides of the neck, doctors will use a sentinel lymph node biopsy—a procedure to check a few key lymph nodes for cancer—to decide which parts of the neck actually need radiation. This personalized approach aims to reduce radiation side effects while keeping treatment just as effective.
Standard throat cancer treatment typically involves radiation to both sides of the neck to catch any microscopic cancer spread that imaging can't detect. However, this broad radiation approach causes permanent side effects like dry mouth and trouble swallowing that significantly hurt quality of life. This trial exists to see whether the new treatment can spare patients unnecessary radiation on one or both sides of the neck by using a reliable biopsy test to guide decisions, resulting in fewer side effects without compromising safety.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo a sentinel lymph node biopsy procedure under general anesthesia, in which doctors inject a tracer and remove a few key lymph nodes to check for cancer. Based on the biopsy results, your radiation therapy plan will be personalized—you may receive radiation to just one side of the neck, both sides, or the primary tumor only, depending on what the biopsy shows. You will then receive standard radiation therapy (with or without chemotherapy) as planned, and your medical team will follow you over time to monitor how well the treatment works and what side effects you experience.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Netherlands